Cardiac amyloidosis: the role of multiimaging, from the simple to the complex

Authors

  • Carlos Izurieta Servicio de Cardiología y Ecocardiografía. Sanatorio de los Arcos. Buenos Aires. Argentina
  • Alfredo Larraburu Servicio de Cardiología y Ecocardiografía. Sanatorio de los Arcos. Buenos Aires. Argentina
  • Facundo Verón Servicio de Cardiología y Ecocardiografía. Sanatorio de los Arcos. Buenos Aires. Argentina
  • Luis Gariglio Servicio de Cardiología y Ecocardiografía. Sanatorio de los Arcos. Buenos Aires. Argentina
  • Juan Pablo Rezzónico Servicio de Cardiología y Ecocardiografía. Sanatorio de los Arcos. Buenos Aires. Argentina
  • Sergio Muryan Jefe del Servicio de Cardiología. Sanatorio de los Arcos. Buenos Aires. Argentina

DOI:

https://doi.org/10.37615/retic.n4a5

Keywords:

cardiac amyloidosis, cardiac multi-imaging, global longitudinal strain, cardiac magnetic resonance.

Abstract

We present a comprehensive review about the role of cardiac multi-imaging in the diagnosis and management of amyloidosis.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Liu D, Hu K, Niemann M, et al. Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy. Circ Cardiovasc Imaging. 2013; 6: 1066 – 72. DOI: https://doi.org/10.1161/CIRCIMAGING.113.000683

Zamorano JL, Lancellotti P, Rodríguez Muñoz DR, et al. 2016 ESC Position paper on cáncer treatments and ardiovascular toxicity developed under the auspices of the ESC Comittee for Practice Guidelines. Eur Heart J. 2016; 37 (36): 2768 – 801. DOI: https://doi.org/10.1093/eurheartj/ehw211

Falk R, Alexander K, Liao R, et al. AL (Light-chain) cardiac amyloidosis. A review of diagnosis and therapy. J Am Coll Cardiol. 2016; 68: 1323 – 41. DOI: https://doi.org/10.1016/j.jacc.2016.06.053

Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003; 349: 583 – 96. DOI: https://doi.org/10.1056/NEJMra023144

Ng B, Connors L, Davidoff R, et al. Senile systemic amyloidosis presenting with heart failure A comparisson with light chain-associated amyloidosis. Arch Int Med. 2005; 165: 1425 – 29. DOI: https://doi.org/10.1001/archinte.165.12.1425

Quarta C, Solomon S, Uraizee I, et al. Left ventricular structure and function in Transthyretin-related versus Light-chain cardiac amyloidosis. Circulation. 2014; 129: 1840 – 9. DOI: https://doi.org/10.1161/CIRCULATIONAHA.113.006242

Campanile A, Sozzi F, Canetta C, et al. Cardioverter-defibrillator implantation in mieloma-associated cardiac amyloidosis. Exp Clinical Cardiol. 2013; 18 (1): 31 – 4.

Kojima T, Imai Y, Fujiu K, et al. Anti.arrhythmic device therapy has limits in improving the prognosis of patients with cardiac amyloidosis. J Arrhythm. 2012; 28: 242 – 46. DOI: https://doi.org/10.1016/j.joa.2012.01.002

Selvanayagam J, Hawkins P, Paul B, et al. Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol. 2007; 50: 2101 – 10. DOI: https://doi.org/10.1016/j.jacc.2007.08.028

Mishra S, Guan J, Plovie E, et al. Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish. Am J Physiol Heart Circ Physiol. 2013; 305: H95-103. DOI: https://doi.org/10.1152/ajpheart.00186.2013

Syed I, Glockner J, Feng D, et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. J Am Coll Cardiol Img. 2010; 3: 155 – 64. DOI: https://doi.org/10.1016/j.jcmg.2009.09.023

Murtagh B, Hammill S, Gertz M, et al. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol. 2005; 95: 535 – 7. DOI: https://doi.org/10.1016/j.amjcard.2004.10.028

Mussinelli R, Salinaro F, Alogna A, et al. Diagnostic and prognostic value of low QRS voltajes in cardiac AL amyloidosis. Ann Noninvasive Electrocardiol. 2013; 18: 271 – 80. DOI: https://doi.org/10.1111/anec.12036

Kruszelnicka O, Chmiela M, Razny M, et al. Cardiac AL amyoloidosis. JRCD. 2016; 2: 245 – 53. DOI: https://doi.org/10.20418/jrcd.vol2no8.246

Phelan D, Collier P, Thavendiranathan P, et al. Relative apical sparing of longitudinal strain using two-dimensional spleckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012; 98: 1442 – 8. DOI: https://doi.org/10.1136/heartjnl-2012-302353

Ternacle J, Bodez D, Guellich A, et al. Causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis. J Am Coll Cardiol Img. 2016; 9: 126 – 38. DOI: https://doi.org/10.1016/j.jcmg.2015.05.014

Salinaro F, Meier-Ewert H, Miller E, et al. Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis. Eur Heart J Cardiol Img. 2016; 0: 1 – 8.

Buss S, Emami M, Mereles D, et al. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis incremental value compared with clinical and biochemical markers. J Am Coll Cardiol. 2012; 60: 1067 – 76. DOI: https://doi.org/10.1016/j.jacc.2012.04.043

Fontana M, Chung R, Hawkins P, et al. Cardiovascular magnetic resonance for amyloidosis. Heart Fail Rev. 2015; 20: 133 – 44. DOI: https://doi.org/10.1007/s10741-014-9470-7

Pozo E, Kanwar A, Deochand R, et al. Cadiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis. Heart. 2014; 100: 1688 – 95. DOI: https://doi.org/10.1136/heartjnl-2014-305710

Maceira A, Joshi J, Prasad S, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005; 111: 186 – 93. DOI: https://doi.org/10.1161/01.CIR.0000152819.97857.9D

Banypersad S, Fontana M, Maestrini V, et al. T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J. 2015; 36: 244 – 51. DOI: https://doi.org/10.1093/eurheartj/ehu444

Fontana M, Pica S, Reant P, et al. Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circula- tion. 2015; 132: 1570 – 9. DOI: https://doi.org/10.1161/CIRCULATIONAHA.115.016567

Downloads

Published

2017-04-30

How to Cite

1.
Izurieta C, Larraburu A, Verón F, Gariglio L, Rezzónico JP, Muryan S. Cardiac amyloidosis: the role of multiimaging, from the simple to the complex. Rev Ecocardiogr Pract Otras Tec Imag Card (RETIC) [Internet]. 2017 Apr. 30 [cited 2024 Nov. 23];(4):21-5. Available from: https://imagenretic.org/RevEcocarPract/article/view/59

Issue

No. 4 (2017): Journal of Practical Echocardiography and Other Cardiac Imaging Techniques

Section

CLINICAL CASES

License

Copyright (c) 2017 Carlos Izurieta, Alfredo Larraburu, Facundo Verón, Luis Gariglio, Juan Pablo Rezzónico, Sergio Muryan

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

RETIC is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license https://creativecommons.org/licenses/by-nc-nd/4.0 which allows sharing, copying and redistribution of the material in any medium or format, under the following terms:

  • Attribution: you must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests that the licensor endorses you or your use.
  • Non-commercial: you may not use the material for commercial purposes.
  • No Derivatives: if you remix, transform or build upon the material, you may not distribute the modified material.
  • No Additional Restrictions: you may not apply legal terms or technological measures that legally restrict others from doing anything permitted by the license.
Crossref
Scopus
Google Scholar
Europe PMC